Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunosuppressant
>>
Phase 1
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
AMP-110
/ AstraZeneca, Daiichi Sankyo
BRE-AD01
/ Brexogen
HS632
(omalizumab biosimilar) / Zhejiang Hisun
RBL001/RBL002
/ BioNTech
avoplacel
(PLX-R18) / Pluri
AVT23
(omalizumab biosimilar) / Alvotech, Advanz Pharma
CS-0777
/ Daiichi Sankyo
DS-2741a
/ Daiichi Sankyo
recombinant human Complement Receptor Type 1
(CDX-1135) / Celldex
